Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Reverso

K-Number: K212107 · 2021-11-10

Decision Date2021-11-10
Product CodeGEI
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

Reverso is the device name listed in this FDA 510(k) record. The listed applicant is Intelis Instruments , Ltd.. It received FDA 510(k) clearance on 2021-11-10 under 510(k) number K212107. The device is classified under product code GEI. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Reverso?

Reverso is a medical device that received FDA 510(k) clearance on 2021-11-10. The listed applicant is Intelis Instruments , Ltd.. The 510(k) number is K212107.

When did Reverso receive FDA 510(k) clearance?

Reverso received FDA 510(k) clearance on 2021-11-10, under 510(k) number K212107.

Who is the listed applicant for Reverso?

The FDA 510(k) record lists Intelis Instruments , Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Reverso?

The FDA product code for Reverso is GEI.

Related Devices (Code: GEI)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.